Chronic high-altitude hypoxia exacerbates cognitive impairment and Alzheimer’s disease pathology
- 20 March 2026
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 111 (1) , 422-432
Abstract
Background: Chronic hypoxia has been acknowledged as a significant risk factor for Alzheimer's disease (AD), yet the impact of high-altitude hypoxia on AD pathogenesis remains poorly understood. Objective: This study aims to investigate the effects of chronic high-altitude hypoxia on cognitive function and AD-related pathology. Methods: A cross-sectional cohort comprising 186 high-altitude migrants (HAM) and 378 high-altitude natives (HAN) was recruited for a preliminary assessment. We further conducted 101 HAM, 135 HAN, and 66 low-altitude controls (LA) for plasma biomarkers research. Plasma Aβ 40 , Aβ 42 , and T-tau levels were quantified by SIMOA. In parallel, APP/PS1 mice were exposed to hypobaric hypoxia (simulated at 5,500 m) or normoxia for 30 days, followed by behavioral tests, brain immunohistochemistry, and transcriptomic/proteomic analyses. Results: HAM subjects exhibited significant deficits in Montreal Cognitive Assessment scores and delayed recall subscores compared to LA controls, with both measures showing a positive correlation with peripheral oxygen saturation (SpO₂). Notably, HAN showed preserved memory despite lower overall cognitive scores. Plasma levels of amyloid-β (Aβ) 40 , Aβ 42 , and Aβ 42 /Aβ 40 ratio were significantly lower in both HAM and HAN groups compared to the LA group. In mice, chronic hypoxia exacerbated hippocampal Aβ deposition and induced spatial memory decline. Multi-omics analyses revealed the upregulation of oxidative stress and neuroinflammatory pathways and identified S100A8/A9 as a potential key mediator in hypoxia-accelerated AD pathology. Conclusions: Our findings demonstrate that chronic high-altitude hypoxia contributes to cognitive decline and AD-related pathological changes, likely mediated by Aβ burden and oxidative stress. High-altitude hypoxia might be an important environmental risk factor for AD.Keywords
Funding Information
- National Natural Science Foundation of China (82101499)
- National Natural Science Foundation of Chongqing, China (CSTB2022NSCQ-MSX1100)
- Natural Science Foundation of Shigatse, China (None)
This publication has 24 references indexed in Scilit:
- Oxygen metabolism abnormality and Alzheimer's disease: An updateRedox Biology, 2023
- Consistent differences in brain structure and functional connectivity in high-altitude native Tibetans and immigrantsBrain Imaging and Behavior, 2023
- Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohortAlzheimer's & Dementia, 2022
- Emerging roles of oxidative stress in brain aging and Alzheimer's diseaseNeurobiology of Aging, 2021
- Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunctionNeurobiology of Disease, 2019
- Hypobaric hypoxia impairs cued and contextual fear memory in ratsBrain Research, 2018
- Oxidative stress and pro-inflammatory cytokines may act as one of the signals for regulating microRNAs expression in Alzheimer’s diseaseMechanisms of Ageing and Development, 2017
- Pathological role of hypoxia in Alzheimer's diseaseExperimental Neurology, 2010
- Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemiaActa Neuropathologica, 2008
- Inflammatory S100A9 and S100A12 proteins in Alzheimer's diseaseNeurobiology of Aging, 2006